January 1, 2016

Principal Investigator(s): 
Timothy Sterling, M.D.

Identifying Innovative Bacterial and Host-Mediated Biomarkers of Treatment Response to Tuberculosis Chemotherapy (RePORT SA) (CRDF # OISE-9531011) 
RePORT SA initiated in 2016 
Funding provided through the South African Medical Research Council (SAMRC), with funds from the South African Department of Health (NDoH), and National Institute of Allergy and Infection Diseases (NIAID) and National Institute of Health (NIH) & PEPFAR